beta-3 agonist
Showing 1 - 25 of >10,000
Overactive Bladder Syndrome Trial run by the (Vaginal estrogen, Mirabegron 50 MG [Myrbetriq])
Recruiting
- Overactive Bladder Syndrome
- Vaginal estrogen
- Mirabegron 50 MG [Myrbetriq]
-
Bethesda, MarylandWalter Reed National Military Medical Center
Nov 3, 2022
Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)
Recruiting
- Healthy
- Salbutamol 400mcg
- +2 more
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Sep 5, 2023
Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)
Recruiting
- Sjogren's Syndrome
- Overactive Bladder Syndrome
- mirabegron
- oxybutynin, tolterodine, solifenacin
-
Taichung, TaiwanChina Medical University Hospital
Aug 8, 2021
Urgency Urinary Incontinence Trial in United States (Beta3-Agonists, Adrenergic, OnabotulinumtoxinA 100 UNT [Botox])
Not yet recruiting
- Urgency Urinary Incontinence
- Beta3-Agonists, Adrenergic
- OnabotulinumtoxinA 100 UNT [Botox]
-
Birmingham, Alabama
- +4 more
Mar 28, 2023
Overactive Bladder Syndrome Trial in Banqiao (Mirabegron, Solifenacin)
Recruiting
- Overactive Bladder Syndrome
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far-Eastern Memorial Ho
Feb 7, 2022
Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics Trial in Seoul (Mirabegron
Active, not recruiting
- Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics
- Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Trial in Melbourne, Sydney, Copenhagen Ø (Mirabegron, Placebo)
Completed
- Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)
- Mirabegron
- Placebo
-
Melbourne, Australia
- +2 more
Oct 14, 2020
Moderate Asthma Trial (Long-Acting Beta Agonist)
Not yet recruiting
- Moderate Asthma
- Long-Acting Beta Agonist
- (no location specified)
Feb 24, 2023
Overactive Bladder Syndrome, Detrusor Overactivity Trial (Mirabegron 50 MG, Solifenacin Succinate 5 MG)
Not yet recruiting
- Overactive Bladder Syndrome
- Detrusor Overactivity
- Mirabegron 50 MG
- Solifenacin Succinate 5 MG
- (no location specified)
Jan 25, 2021
Thermogenesis Trial in Basel (Fenoterol, Mild cold exposure)
Recruiting
- Thermogenesis
- Fenoterol
- Mild cold exposure
-
Basel, SwitzerlandUniversity Hospital Basel, Dept. of Endocrinology
Apr 27, 2022
Impact of Mirabegron on Erectile Function in BPH Patients
Unknown status
- Males With Benign Prostatic Hyperplasia Symptoms
- Mirabegron 50 MG
- Alpha Blockers
- (no location specified)
Aug 6, 2020
Voiding Disorders, Overactive Bladder Trial (Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin)
Not yet recruiting
- Voiding Disorders
- Overactive Bladder
- Beta3-Agonists, Adrenergic
- Anticholinergic drug, Solifenacin
- (no location specified)
Feb 13, 2022
Overactive Bladder, Dementia, Lower Urinary Tract Symptoms Trial in Houston, Temple (Anticholinergic, Beta-3 Agonists,
Unknown status
- Overactive Bladder
- +3 more
- Anticholinergic
- +3 more
-
Houston, Texas
- +1 more
Apr 1, 2020
Moderate to Severe Asthma Exacerbation Trial in Poitiers (Standard Nebulization, A - Vibrating mesh nebulization, B - Vibrating
Not yet recruiting
- Moderate to Severe Asthma Exacerbation
- Standard Nebulization
- +2 more
-
Poitiers, FranceUniversity Hospital of Poitiers
Jan 11, 2023
Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)
Recruiting
- Type 2 Diabetes
- Obesity
- Formoterol Fumarate 12 micrograms Inhalation Powder
- +8 more
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Sep 22, 2022
Reversibility of Bronchial Obstruction in Children Born Preterm
Recruiting
- Bronchopulmonary Dysplasia
- +6 more
-
Prague, CzechiaFirst faculty of Medicine, Charles university.
Oct 29, 2023
Transient Tachypnea of the Newborn Trial (Epinephrine Inhalation Solution, Salbutamol, Saline Inhalants)
Completed
- Transient Tachypnea of the Newborn
- Epinephrine Inhalation Solution
- +2 more
- (no location specified)
Aug 7, 2021
Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Not yet recruiting
- Copd Patients
- IL B,IL 3 in nasal swap and serum
- (no location specified)
Aug 4, 2023
Exercise-Induced Lactic Acidemia Trial in Saskatoon (Beta-alanine, Maltodextrin)
Recruiting
- Exercise-Induced Lactic Acidemia
- Beta-alanine
- Maltodextrin
-
Saskatoon, Saskatchewan, CanadaUniversity of Saskatchewan
Mar 14, 2023
Hypertrophy, Left Ventricular Trial in Worldwide (drug, procedure, radiation)
Active, not recruiting
- Hypertrophy, Left Ventricular
- mirabegron
- +6 more
-
Brussels, Belgium
- +8 more
Sep 28, 2021
Fabry Disease Trial in Seoul (Fabagal® (Agalsidase beta), Active comparator (Agalsidase beta))
Recruiting
- Fabry Disease
- Fabagal® (Agalsidase beta)
- Active comparator (Agalsidase beta)
-
Seoul, Songpa-gu, Korea, Republic ofSeoul Asan Center
Oct 10, 2023
Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Durvalumab
- Rintatolimod
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 23, 2023
Central Precocious Puberty Trial (Debio 4326)
Not yet recruiting
- Central Precocious Puberty
- Debio 4326
- (no location specified)
Nov 8, 2023
Overactive Bladder Trial in Hillsborough, Raleigh (Lactobacillus Probiotic Capsule, Matching Lactobacillus Probiotic Placebo
Completed
- Overactive Bladder
- Lactobacillus Probiotic Capsule
- Matching Lactobacillus Probiotic Placebo Capsule
-
Hillsborough, North Carolina
- +1 more
May 8, 2020